Dr. Caner Z. Dinlenc, MD

Dr. Dinlenc practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Dinlenc's NPI, 1730162173, was assigned on November 21, 2005. Dr. Dinlenc graduated from Boston University School Of Medicine in 1993. Dr. Dinlenc holds New York license 213048.

Dr. Dinlenc's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Dinlenc's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Dinlenc is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Dinlenc to 1 more hospital, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinlenc practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dinlenc's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dinlenc is board certified in urology by the American Board of Urology. Dmand AI has Dr. Dinlenc's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Dinlenc treats.

CMS data shows 299 Medicare services from Dr. Dinlenc across 7 procedure codes in 2024, for 135 Medicare patients. Medicare paid $20,434 for them.

CMS counts 135 Medicare patients who saw Dr. Dinlenc in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dinlenc's median patient age at 59, with 41% women.

In 2024, Dr. Dinlenc wrote 384 Medicare Part D claims for 128 patients. 99% of them were for generic drugs. CMS names the drug for 310 of them, across 5 drugs with 11 or more claims each, at $2,738 in total drug cost. In 2023, CMS named 339 claims across 5 drugs.

Dr. Dinlenc accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Dinlenc, published from 2010 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Laparoscopy, Ureter and Kidney Pelvis. Dr. Dinlenc has published most often in J Endourol. Dr. Dinlenc's most frequent co-authors are Eric W. Gerber, MD, Paulos Yohannes, MD and Benjamin Farrel Katz, MD.

CMS Open Payments shows 49 general payments to Dr. Dinlenc from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 57% of the total. Boston Scientific Corporation paid the most, $1,285.

Dmand AI lists 5 awards for Dr. Dinlenc, most recently New York Magazine: Top Doctors in 2014.

Dr. Dinlenc graduated from Boston University School Of Medicine in 1993. Dr. Dinlenc is a member of ACS.

Dr. Dinlenc is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.